Germany Infection Control Market Size, Share, Opportunities, COVID-19 Impact, And Trends By Product (Disinfectants, Sterilization (Low-Temperature Sterilization, Heat Sterilization, Contract Sterilization)), By End User Industry (Healthcare, Food And Beverage, Chemical) - Forecasts From 2022 To 2027

  • Published : Aug 2022
  • Report Code : KSI061613393
  • Pages : 90

The Germany infection control market is projected to grow at a compound annual growth rate of 11.79% over the forecast period to attain a market size of US$3,117.514 million in 2027, from US$1,429.013 million in 2020. The market is projected to surge in the forecast period with the high health expenditure in the country. Additionally, with the country's growing senior population, health expenditure will further increase, fueling the market demand in the forecast period. Chronic diseases have increased the need for regular visits to hospitals and clinics, propagating spurring market growth in the forecast period. Furthermore, effective cancer care in Germany, leading to high cancer survival rates, is burgeoning the market demand during the next five years. According to the Federal Ministry of Health, there has been substantial growth in coronavirus infections in Germany. This will further provide an opportunity for the market to thrive in 2020 to prevent the further spreading spread of infections from this deadly virus.

Effective cancer care in the country is poised to surge and spur the growth of the infection control market in the forecast period.

The country is accountable for many cancer survivors, especially for breast, cervical, and colorectal cancer. The major reason is the high screening rates leading to early cancer detection, which is considered crucial for providing effective care to patients on time. Hence, an early diagnosis is the most important factor in offering effective cancer care. Furthermore, the rise in regular check-ups for effective cancer treatment proliferates market growth in the forecast period.

Germany's hospitals and specialized cancer centres are well-equipped to provide comprehensive care for all cancer patients and their families. Additionally, these institutes employ the most recent medical equipment and offer the most modern cancer treatment. Hence, this has further surged and boosted the high market demand for state-of-the-art infection control products to keep pace with the advanced healthcare system here. Even the standard hospitals in the country use the latest technologies or high-tech imaging to detect tumours early. A high-resolution MRI or three-dimensional computed tomography (3D CT scan) is used to diagnose cancer. The cancer diagnosis is performed utilizing high-resolution MRI or three-dimensional computed tomography (3D CT scan).

Hospital admissions and growing surgical activity augment the market demand in the forecast period.

As per OECD estimates, the hospital admissions and surgical activity rates are very high. Additionally, this is increasing market demand during the anticipated period. The factors affecting the rate of hospital admissions are due to the growing geriatric population (one of the oldest populations in Europe with a low fertility rate), further influencing market demand during the projection timeframe.

The country has the highest number of coronary revascularization procedures, with more than 400 procedures performed per 100,000 people (source: OECD, 2016 data). The country is recorded to have the highest number of coronary revascularization procedures, accounting for more than 400 procedures per 100,000 population (source: OECD, 2016 data). The European Union estimates that in 2017, transluminal coronary angioplasties were most common in Germany and Croatia. In Germany, transluminal coronary angioplasty was performed at an average rate of 413 per 100,000 inhabitants in the same year.

COVID-19 SCENARIO

The pandemic of COVID-19 had a positive impact on German infection control market. The pandemic has caused havoc on healthcare systems around the world, with hospitals becoming overcrowded as the number of patients climbs. Temporary hospitals are being built to handle the influx of cases. The spread of COVID-19 has caused a boom in demand for cleaning and disinfection products because of the heightened awareness about cleanliness, health, and safety. However, it is anticipated that the infection control business will suffer severely in the post-COVID situation.

Germany Infection Control Market Scope:

 

Report Metric Details
 Market Size Value in 2020  US$1,429.013 million
 Market Size Value in 2027  US$3,117.514 million
 Growth Rate  CAGR of 11.79% from 2020 to 2027
 Base Year  2020
 Forecast Period  2022–2027
 Forecast Unit (Value)  USD Million
 Segments Covered  Product, And End User Industry
 Companies Covered  3M, Medtronic, STERIS plc, Cantel Germany GMBH, Ecolab
 Customization Scope  Free report customization with purchase

 

Segmentation:

  • By Product
    • Disinfectant
    • Sterilization
      • Low temperature Sterilization
      • Heat Sterilization
      • Contract Sterilization
  • By End User Industry
    • Healthcare
    • Food and Beverage
    • Chemical

1. Introduction
1.1. Market Overview
1.2. COVID-19 Scenario
1.3. Market Definition
1.4. Market Segmentation

2. Research Methodology
2.1. Research Data
2.2. Assumptions

3. Executive Summary
3.1. Research Highlights

4. Market Dynamics
4.1. Market Drivers
4.2. Market Restraints
4.3. Porters Five Forces Analysis
4.3.1.  Bargaining Power of Suppliers
4.3.2. Bargaining Power of Buyers
4.3.3. Threat of New Entrants
4.3.4.  Threat of Substitutes
4.3.5. Competitive Rivalry in the Industry
4.4. Industry Value Chain Analysis

5.  Germany Infection Control Market by Product
5.1.  Introduction
5.2. Disinfectant
5.3. Sterilization 
5.3.1. Low-Temperature Sterilization
5.3.2. Heat Sterilization
5.3.3. Contact Sterilization

6. Germany Infection Control Market by End-User Industry
6.1.  Introduction
6.2. Healthcare
6.3. Food and Beverage
6.4. Chemical

7. Competitive Environment and Analysis
7.1. Major Players and Strategy Analysis
7.2.  Emerging Players and Market Lucrativeness
7.3.  Mergers, Acquisitions, Agreements, and Collaborations
7.4.  Vendor Competitiveness Matrix

8. Company Profiles 
8.1. 3M
8.2.  Medtronic
8.3. STERIS plc
8.4.  Cantel Germany GMBH
8.5.  Ecolab

3M

Medtronic

STERIS plc

Cantel Germany GMBH

Ecolab